期刊文献+

MiRNA-146a与不稳定型心绞痛冠状动脉病变程度的相关研究

Correlation between miRNA-146a and severity of coronary artery lesions of unstable angina pectoris
下载PDF
导出
摘要 目的 观察不稳定型心绞痛(UAP)患者血清微小RNA(miRNA)-146a rs2910164基因多态性的分布特征,探讨miRNA-146a表达水平与冠状动脉(冠脉)病变严重程度的相关性.方法 入选2018年6月至12月于徐州医科大学附属医院心内科就诊的UAP患者100例(UAP组),根据Gensini评分评估患者冠脉病变严重程度,按四分位法将入选的UAP患者分为4个亚组,同期纳入冠脉造影无明显异常的100例患者作为正常对照组,检测miRNA-146a rs2910164基因的多态性及表达水平,观察两组人群中miRNA-146a基因多态性的分布情况,并评估UAP各亚组患者miRNA-146a表达水平与冠脉Gensini评分的关系.结果 与正常对照组相比,CC+CG基因型在UAP患者中更常见,且CC+CG基因型携带者比非携带者罹患不稳定型心绞痛的风险高2.389倍(χ2=5.093,P=0.024,OR=2.389,95%CI:1.170-4.878).UAP组miRNA-146a表达水平明显高于正常对照组(Z=8.664,P<0.001),其各亚组中也存在差异(t/χ2=4.613,P=0.023);随着miRNA-146a表达水平的升高,Gensini评分也随之升高.结论 血液中miRNA-146a基因型在人群中分布存在差异,与GG基因型相比,携带CC+GC基因型的人群罹患UAP的可能性更大.UAP患者血液中miRNA-146a表达水平明显高于正常人,且随着miRNA-146a表达水平的升高,Gensini评分也呈增高趋势. Objective To observe the distribution characteristics of rs2910164 gene polymorphism of serum micro-RNA(miRNA)-146a,and discuss the correlation between expression of miRNA-146a and severity of coronary artery lesions in patients with unstable angina pectoris(UAP).Methods UAP patients(n=100,UAP group)were chosen from Department of Cardiology in Affiliated Hospital of Xuzhou Medical University from June 2018 to Dec.2018.The severity of coronary artery lesions was reviewed according to Gensini scoring and UAP patients were divided into 4 subgroups according to quartile method.At the same time the patients(n=100)without significant outcomes of abnormal coronary angiography were chosen into normal control group.The miRNA-146a rs2910164 gene polymorphism and expression were detected.The distribution of miRNA-146a gene polymorphism was observed in 2 groups.The relationship between miRNA-146a expression and coronary artery Gensini scores was reviewed in all subgroups.Results Compared with normal control group,CC+CG genotype was more common in UAP group,and UAP risk was 2.389 times higher in CC+CG genotype carriers than that in non-carriers(χ2=5.093,P=0.024,OR=2.389,95%CI:1.170~4.878).The expression of miRNA-146a was significantly higher in UAP group than that in normal control group(Z=8.664,P<0.001),and there was difference among different subgroups(t/χ2=4.613,P=0.023).Along with the expression of miRNA-146a increased,Gensini scores also increased.Conclusion The distribution of miRNA-146a genotypes is different in different population.The risk of UAP is higher in CC+GC genotype carriers than that in GG genotype carriers.The expression of miRNA-146a is significantly higher in UAP patients than that in normal people,and along with the increases of miRNA-146a expression,Gensini scores will increase.
作者 张琳赟 薛同能 何雅文 李斌斌 朱红 潘德锋 Zhang Linyun;Xue Tongneng;He Yawen;Li Binbin;Zhu Hong;Pan Defeng(Department of Cardiology,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,China.;不详)
出处 《中国循证心血管医学杂志》 2020年第6期694-697,702,共5页 Chinese Journal of Evidence-Based Cardiovascular Medicine
基金 江苏省徐州市科技项目(KC15SX003)。
关键词 微小RNA 表达水平 基因多态性 GENSINI评分 不稳定型心绞痛 Micro-RNA Expression level Gene polymorphism Gensini scores Unstable angina pectoris
  • 相关文献

参考文献2

二级参考文献37

  • 1张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 3姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 4Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 5Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 6Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 7CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 8Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 9Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 10Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.

共引文献5427

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部